Abstract
Increased activity of urinary N‐acetyl‐β‐d‐glucosaminidase (NAG) can be used as an early indicator of damage to the tubular epithelium. Systemic lupus erythematosus (SLE) is a multisystem autoimmune rheumatic disease. Nephritis is known as the most serious complication of SLE and the strongest predictor of poor outcome. In this study urinary NAG excretion was investigated in 24 SLE patients with normal renal function (serum creatinine ≤1.2 mg/dL) and the results were compared with those from 26 untreated patients with rheumatoid arthritis (RA) and 27 healthy controls. The SLE patients were divided into two groups according to their urinary total protein levels: group A consisted of 16 patients with ≤3.5 g/day proteinuria, and group B consisted of eight patients with nephrotic‐range proteinuria (>3.5 g/day). Serum and urinary creatinine, total urinary protein levels, and urinary NAG excretion were measured in patients with SLE and RA. In addition, serum C3 and C4 levels were determined in the SLE patients. Renal biopsies were performed in all of the SLE patients. Glomerular lesions were classified according to WHO criteria for lupus nephritis (LN) I–V. The Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) was used to assess disease activity. Urinary NAG excretion was significantly higher in the SLE groups than in the healthy controls (P<0.001). In urinary NAG excretion there was also significant difference between SLE groups and RA patients (P<0.001). However, there was no significant difference in NAG excretion between the RA and control groups (P=0.062). Urinary NAG excretion was significantly higher (P<0.05) in group B compared to group A. There were no differences in SLEDAI scores, ages, and serum creatinine levels between study groups (P=0.601, P=0.285, P=0.669, respectively). Elevated SLEDAI values and hypocomplementemia were detected more often in younger patients (P<0.010, r=–0.529 and P<0.010, r=–0.569, respectively). There was a strong positive correlation between proteinuria and urinary NAG activity (P<0.001, r=0.759). These results suggest that the determination of urinary NAG activity may be a useful supplement to the routine biochemical analysis performed on the urine in cases of SLE. J. Clin. Lab. Anal. 19:172–176, 2005. © 2005 Wiley‐Liss, Inc.
Keywords: N‐acetyl‐β‐d‐glucosaminidase, proteinuria, lupus nephritis: rheumatoid arthritis
REFERENCES
- 1. Price RG. The role of NAG (N‐acetyl‐β‐D‐glucosaminidase) in the diagnosis of kidney disease, including the monitoring of nephrotoxicity. Clin Nephrol 1992;38:14–19. [PubMed] [Google Scholar]
- 2. Grande JP. Mechanisms of progression of renal damage in lupus nephritis: pathogenesis of renal scarring. Lupus 1998;7:604–610. [DOI] [PubMed] [Google Scholar]
- 3. Ponticelli C, Moroni G. Flares in lupus nephritis: incidence, impact on renal survival and management. Lupus 1998;7:635–638. [DOI] [PubMed] [Google Scholar]
- 4. Alba P, Bento L, Cuadrado MJ, et al. Anti‐dsDNA, anti‐Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis. Ann Rheum Dis 2003;62:556–559. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Myllykangas‐Luosujärvi RA, Aho K, Isomäki Ha. Mortality in rheumatoid arthritis. Semin Arthritis Rheum 1995;25:193–202. [DOI] [PubMed] [Google Scholar]
- 6. Bazzi C, Petrini C, Rizza V, et al. Urinary N‐acetyl‐β‐glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis. Nephrol Dial Transplant 2002;17:1890–1896. [DOI] [PubMed] [Google Scholar]
- 7. Bosomworth MP, Aparicio SR, Hay AWM. Urine N‐acetyl‐β‐D‐ glucosaminidase–a marker of tubular damage? Nephrol Dial Transplant 1999;14:620–626. [DOI] [PubMed] [Google Scholar]
- 8. Tan EM, Cohen AS, Freis JF. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1277. [DOI] [PubMed] [Google Scholar]
- 9. Golbus J, McCune WJ. Lupus nephritis. Classification, prognosis, immunopathogenesis and treatment. Rheum Dis Clin North Am 1994;20:213–242. [PubMed] [Google Scholar]
- 10. Kashgarian M. New approaches to clinical pathologic correlation in lupus nephritis. Am J Kidney Dis 1982;2:164–169. [PubMed] [Google Scholar]
- 11. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–328. [DOI] [PubMed] [Google Scholar]
- 12. Werner M, Maruhn D, Atoba M. Use of gel filtration in the assay of urinary enzymes. J Chromatog 1969;40:254–263. [DOI] [PubMed] [Google Scholar]
- 13. Maruhn D. Rapid colorimetric assay of β‐galactosidase and N‐acetyl‐β‐glucosaminidase in human urine. Clin Chim Acta 1976;73:453–461. [DOI] [PubMed] [Google Scholar]
- 14. Berden JHM. Lupus nephritis. Kidney Int 1997;52:538–558. [DOI] [PubMed] [Google Scholar]
- 15. Boumpas DT, Balow JE. Outcome criteria for lupus nephritis trials: a critical overview. Lupus 1998;7:622–629. [DOI] [PubMed] [Google Scholar]
- 16. Austin HA. Clinical evaluation and monitoring of lupus kidney disease. Lupus 1998;7:618–621. [DOI] [PubMed] [Google Scholar]
- 17. Fraenkel L, MacKenzie T, Joseph L, Kashgarian M, Hayslett JP, Esdaile JM. Response to treatment as a predictor of longterm outcome patients with lupus nephritis. J Rheumatol 1994;21:2052–2057. [PubMed] [Google Scholar]
- 18. D'Agati VD. Renal disease in systemic lupus erythematosus, mixed connective tissue disease, Sjögren's syndrome, and rheumatoid arthritis In: Jennette JCH, Olson JL, Schwartz MM, Silva FG, editors. Heptinstall's pathology of the kidney. Philadelphia: Lippincott‐Raven; 1998. p 541–624. [Google Scholar]
- 19. Hultberg B, Ravnskov U. The excretion of N‐acetyl‐β‐D‐glucosaminidase in glomerulonephritis. Clin Nephrol 1981;15:33–38. [PubMed] [Google Scholar]
- 20. Burton CJ, Walls J. Proximal tubular cell, proteinuria and tubulointerstitial scarring. Nephron 1994;68:287–293. [DOI] [PubMed] [Google Scholar]
- 21. Falaschi F, Ravelli A, Martignoni A, et al. Nephrotic‐range proteinuria, the major risk factor for early atherosclerosis in juvenile‐onset systemic lupus erythematosus. Arthritis Rheum 2000;43:1405–1409. [DOI] [PubMed] [Google Scholar]
- 22. Hultberg B. Urinary excretion of β‐hexosaminidase in different forms of proteinuria. Clin Chim Acta 1980;108:195–199. [DOI] [PubMed] [Google Scholar]
- 23. Formiga F, Moga I, Pac M, Mitjavila F, Rivera A, Pujol R. Mild presentation of systemic lupus erythematosus in elderly patients assessed by SLEDAI. SLE disease activity index. Lupus 1999;8:462–465. [DOI] [PubMed] [Google Scholar]
- 24. Tucker LB, Menon S, Schaller JG, Isenberg DA. Adult‐ and childhood‐onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br J Rheumatol 1995;34:866–872. [DOI] [PubMed] [Google Scholar]